iBio, Inc.
iBio, Inc.
Insider Sentiment (TTM):
Last Purchase:2026-03-26Last Sale:2023-11-01Shares Purchased (TTM):51,105Shares Sold (TTM):0
Institutional Sentiment:
As of:2026-03-31Institutional Shares Owned:19,415,577Shares Outstanding:119,600,000Institutional Ownership Pct.:16.23%
Earnings Market Reaction:
Filing Date:2026-05-12Price on Filing Date:N/APrevious Close:N/A% Change:N/A
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 48 | 29 | 28 | 9 | 5 | 7 | 11 | 14 | 5 | 3 | 1 | 4 | |||||
Restricted Cash Current | - | - | - | - | - | - | - | - | 1 | 1 | 3 | 3 | |||||
Notes And Loans Receivable Net Current | - | - | - | - | - | - | - | 1 | - | - | - | - | |||||
Common Stock Share Subscribed But Unissued Subscri… | - | - | - | 0 | - | 0 | - | - | - | - | - | 0 | |||||
Accounts Receivable Net Current | - | - | 0 | - | - | - | - | - | - | - | - | - | |||||
Debt Securities Current | 27 | 24 | 21 | - | - | - | - | - | - | - | - | - | |||||
Prepaid Expense And Other Assets Current | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | |||||
Assets Held For Sale Not Part Of Disposal Group Cu… | - | - | - | - | - | - | - | - | 15 | 15 | 18 | 18 | |||||
Assets Current | 77 | 53 | 51 | 10 | 6 | 8 | 12 | 16 | 36 | 20 | 23 | 26 | |||||
Restricted Cash Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Notes And Loans Receivable Net Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | - | - | - | 2 | |||||
Finance Lease Right Of Use Asset | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | |||||
Operating Lease Right Of Use Asset | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | |||||
Property Plant And Equipment Net | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | |||||
Intangible Assets Net Excluding Goodwill | 2 | 4 | 7 | 7 | 6 | 6 | 5 | 5 | 5 | 5 | 5 | 5 | |||||
Prepaid Expense Noncurrent | 0 | - | - | - | - | 0 | - | - | - | - | - | - | |||||
Security Deposit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets | 86 | 64 | 64 | 23 | 19 | 22 | 25 | 29 | 50 | 34 | 38 | 41 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 3 | 3 | 3 | 2 | 1 | 1 | 1 | 0 | 1 | 2 | 2 | 2 | |||||
Accrued Liabilities Current | 2 | 2 | 1 | 1 | 1 | 2 | 1 | 2 | 4 | 4 | 3 | 5 | |||||
Finance Lease Liability Current | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Operating Lease Liability Current | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Secured Debt Current | - | - | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | |||||
Short Term Bank Loans And Notes Payable | - | - | - | - | - | - | - | - | - | - | - | 13 | |||||
Notes Payable Current | - | - | 1 | 1 | 1 | 0 | 0 | 0 | 13 | 13 | 13 | 13 | |||||
Short Term Non Bank Loans And Notes Payable | - | - | - | - | 0 | 1 | - | 0 | - | - | - | - | |||||
Contract With Customer Liability Current | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | - | - | 0 | |||||
Other Liabilities Current | - | - | - | - | - | - | - | - | - | - | - | 2 | |||||
Liabilities Current | 7 | 6 | 6 | 6 | 5 | 5 | 3 | 4 | 21 | 22 | 21 | 22 | |||||
Deferred Revenue Current | - | - | - | - | - | - | - | - | - | - | - | 0 | |||||
Finance Lease Liability Noncurrent | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | |||||
Operating Lease Liability Noncurrent | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | |||||
Secured Long Term Debt | - | - | - | - | - | - | 0 | 0 | - | - | - | 0 | |||||
Liabilities | 8 | 8 | 8 | 8 | 8 | 8 | 7 | 7 | 25 | 25 | 24 | 26 | |||||
Stockholders Equity Inclu… | |||||||||||||||||
Stockholders Equity | |||||||||||||||||
Preferred Stock Value | - | - | - | - | - | - | - | 0 | - | - | - | 0 | |||||
Long Term Notes Payable | - | - | - | - | - | 1 | 1 | 1 | - | - | - | - | |||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital Common Stock | 432 | 403 | 394 | 347 | 338 | 336 | 336 | 335 | 331 | 312 | 308 | 304 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | -0 | 0 | -0 | - | - | - | - | - | - | - | - | - | |||||
Retained Earnings Accumulated Deficit | -355 | -347 | -338 | -332 | -327 | -322 | -318 | -314 | -306 | -303 | -295 | -289 | |||||
Stockholders Equity | 78 | 57 | 56 | 15 | 11 | 14 | 18 | 21 | 25 | 9 | 13 | 15 | |||||
Liabilities And Stockholders Equity | 86 | 64 | 64 | 23 | 19 | 22 | 25 | 29 | 50 | 34 | 38 | 41 | |||||
Allowance For Doubtful Accounts Receivable Current | 0 | 0 | - | - | - | - | - | - | - | - | - | - | |||||
Available For Sale Securities Debt Securities Curr… | 27 | 24 | 21 | - | - | - | - | - | - | - | - | - | |||||
Preferred Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Preferred Stock Shares Authorized | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Common Stock Shares Authorized | 275 | 275 | 275 | 275 | 275 | 275 | 275 | 275 | 275 | 275 | 275 | 275 | |||||
Common Stock Shares Issued | 35 | 30 | 20 | 19 | 10 | 9 | 9 | 9 | 9 | 3 | 1 | 1 | |||||
Shares Outstanding | 35 | 30 | 20 | 19 | 10 | 9 | 9 | 9 | 9 | 3 | 1 | 1 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
0/5
Search a metric to start building a table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
0/1
Search a metric to start building a visual
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -4.00% | 61.60% | 68.00% | 14.98% | -12.78% | -29.96% | 13.04% | 4.35% | -13.04% | - | - | - |
| 2025 | 8.63% | -3.92% | 18.04% | 63.74% | -5.56% | -70.47% | -18.81% | -23.76% | -27.72% | -3.57% | 44.05% | 25.00% |
| 2024 | -75.71% | -76.96% | -80.36% | 5.08% | 244.07% | 49.15% | 32.97% | 5.49% | 8.24% | 33.50% | 29.95% | 40.61% |
| 2023 | - | - | - | - | - | - | -20.21% | -35.11% | -28.72% | 6.90% | -10.34% | -77.76% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 11.88 | 9.04 | 8.39 | 1.59 | 1.12 | 1.76 | 3.37 | 4.08 | 1.69 | 0.91 | 1.11 | 1.19 | |||||
| Quick Ratio | 11.50 | 8.93 | 8.21 | 1.42 | 0.92 | 1.49 | 3.18 | 3.89 | 1.65 | 0.87 | 1.09 | 1.16 | |||||
| Working Capital | 70.75M | 47.47M | 44.72M | 3.62M | 663.00K | 3.58M | 8.24M | 11.83M | 14.71M | -1.85M | 2.31M | 4.15M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 0.11 | 0.14 | 0.14 | 0.56 | 0.68 | 0.56 | 0.38 | 0.35 | 1.02 | 2.70 | 1.85 | 1.68 | |||||
| Interest Coverage TTM | -202.51 | -145.56 | -107.05 | -87.75 | -73.74 | -68.85 | -77.03 | -96.71 | -141.01 | -185.12 | -245.96 | -353.53 | |||||
| Debt Ratio | 0.10 | 0.12 | 0.13 | 0.36 | 0.40 | 0.36 | 0.28 | 0.26 | 0.50 | 0.73 | 0.65 | 0.63 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.00 | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Days Sales Outstanding TTM | - | - | 47.45 | - | - | - | - | - | - | - | - | - | |||||
| Receivables Turnover TTM | - | - | 7.69 | - | - | - | - | - | - | - | - | - | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -0.23 | -0.25 | -0.38 | -1.75 | -2.13 | -2.11 | -2.68 | -6.50 | -6.24 | -14.70 | -43.93 | -106.23 | |||||
| Free Cash Flow Per Share TTM | -0.19 | -0.19 | -0.33 | -1.46 | -1.60 | -1.79 | -1.99 | -4.90 | -5.16 | -13.27 | -27.54 | -72.04 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Operating Profit Margin TTM | -14,479.50% | -8,491.00% | -4,089.40% | -4,650.50% | -2,924.00% | -3,661.18% | -5,686.18% | -5,118.15% | -12,126.67% | -20,733.00% | -53,620.00% | - | |||||
| Net Profit Margin TTM | -13,803.00% | -8,245.67% | -4,021.60% | -4,594.25% | -3,650.78% | -4,541.88% | -8,418.18% | -7,663.69% | -15,441.33% | -27,284.00% | -105,252.00% | - | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | -65.22% | -29.41% | 81.82% | 23.08% | 283.33% | 325.00% | 450.00% | - | - | -94.44% | -97.22% | -100.00% | |||||
| Net Income Growth (1Y) | 31.51% | 28.15% | -13.14% | -26.22% | -9.37% | -29.25% | -56.01% | -61.69% | -69.54% | -66.37% | -11.54% | 29.24% | |||||
| EPS Growth (1Y) | -89.16% | -88.19% | -85.85% | -73.08% | -65.88% | -85.62% | -93.90% | -93.88% | -94.59% | -91.11% | -67.36% | -7.92% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -8.23 | -7.73 | -2.19 | -0.43 | -1.89 | -1.16 | -0.83 | -0.32 | -0.65 | -0.09 | -0.14 | -0.11 | |||||
| P/B TTM | 2.93 | 3.38 | 0.78 | 0.54 | 3.48 | 1.61 | 1.08 | 0.38 | 0.61 | 0.28 | 0.54 | 0.49 | |||||
| P/S TTM | 1,136.20 | 637.76 | 87.95 | 19.95 | 68.95 | 52.64 | 69.69 | 24.87 | 100.50 | 25.43 | 143.76 | - | |||||
| Market Cap | 227.24M | 191.33M | 43.97M | 7.98M | 39.65M | 22.37M | 19.17M | 8.08M | 15.07M | 2.54M | 7.19M | 7.47M | |||||
| Enterprise Value | 179.38M | 162.43M | 16.36M | 70.24K | 35.53M | 16.38M | 9.31M | 10.49M | 21.72M | 11.63M | 15.40M | 13.85M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -22.17M | -19.19M | -17.30M | -15.32M | -15.77M | -16.30M | -17.14M | -18.76M | -19.18M | -24.63M | -32.99M | -44.09M | |||||
| Net Debt | -47.86M | -28.90M | -27.62M | -7.91M | -4.12M | -6.00M | -9.85M | 2.40M | 6.65M | 9.09M | 8.22M | 6.38M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
2026-03-26Purchase
Owner: Banjak, Marc
Title: Chief Legal Officer
Shares: 13,934
Price/Share: $1.70
Value: $23,687.80
Shares Owned: 25,000
Relationship: Officer
Ownership: Direct
2026-03-19Purchase
Owner: Duran, Felipe
Title: Chief Financial Officer
Shares: 24,835
Price/Share: $2.02
Value: $50,166.70
Shares Owned: 35,974
Relationship: Officer
Ownership: Direct
2026-03-19Purchase
Owner: Brenner, Martin
Title: See Remarks
Shares: 12,336
Price/Share: $2.02
Value: $24,918.72
Shares Owned: 30,652
Relationship: Director,Officer
Ownership: Direct
2025-01-10Purchase
Owner: Arkowitz, David
Title: -
Shares: 18,382
Price/Share: $2.72
Value: $49,999.04
Shares Owned: 18,382
Relationship: Director
Ownership: Direct
2025-01-10Purchase
Owner: Banjak, Marc
Title: Chief Legal Officer
Shares: 9,191
Price/Share: $2.72
Value: $24,999.52
Shares Owned: 11,066
Relationship: Officer
Ownership: Direct
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
No data available for chart
2026-03-31
16.23%
Inst. Shares: 19,415,577
Shares Outstanding: 119,600,000
2025-12-31
16.48%
Inst. Shares: 16,338,963
Shares Outstanding: 99,133,000
2025-09-30
6.59%
Inst. Shares: 3,494,007
Shares Outstanding: 52,981,000
2025-06-30
30.13%
Inst. Shares: 3,163,617
Shares Outstanding: 10,499,000
2025-03-31
26.23%
Inst. Shares: 2,587,118
Shares Outstanding: 9,862,000
iBio, Inc. (IBIO) — SEC Financial Statements & Analysis
iBio, Inc. (IBIO) is a pharmaceutical preparations company, incorporated in DE. iBio, Inc. trades on Nasdaq as: IBIO. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), iBio, Inc. reported a -65.22% year-over-year revenue growth, a Debt-to-Equity ratio of 0.11x, a Price-to-Sales (P/S) ratio of 1136.20x (TTM), a Price-to-Book (P/B) ratio of 2.93x (TTM), at a market cap of $227.24M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- -65.22%
- Debt To Equity
- 0.11x
- P/S TTM
- 1136.20x
- P/B TTM
- 2.93x
- Market Cap
- $227.24M
Data as of 2026-03-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is iBio, Inc. in?
iBio, Inc. (IBIO) operates in the Pharmaceutical Preparations industry.
What is IBIO's market cap?
iBio, Inc. (IBIO) has a market capitalization of $227.24M as of 2026-03-31.
What exchange does IBIO trade on?
iBio, Inc. (IBIO) trades on the Nasdaq.
Where is iBio, Inc. incorporated?
iBio, Inc. is incorporated in DE.